公开(公告)号：US3842069A

公开(公告)日：1974-10-15

申请号：US37238773

申请日：1973-06-21

Applicant: ABBOTT LAB

Inventor： JONES P ,  MARTIN J ,  TADANIER J ,  MCALPINE J ,  PAUVLIK J

IPC: C07H17/08 ,  C07C129/18

CPC classification number: C07H17/08

Abstract: 1. A 4"-DEOXY-4"-OXOERYTHROMYCIN COMPOUND SELECTED FROM THE GROUP CONSISTING OF

2,10-DI(O=),4,5,7,9,11,13,-HEXA(H3C-),4-((4,6-DI(H3C-),

4-(H3C-O-),5-(O=),6-(H3C-)-TETRAHYDROPYR-2-YL)-O-),6-

((3-(R1-O-),4-((H3C)2-N-),6-(H3C-)-TETRAHYDROPYR-2-YL)-

O-),7-(HO-),12-(R-O-),14-(H5C2-)-OXACYCLOTETRADECANE

WHERE R IS -CHR2SR3 WHERE R'' IS HYDROGEN OR LOWERALKYL, R3 IS LOWERALKYL AND R1 IS HYDROGEN OR LOWERALKANOYL AND;

2-(O=),3,5,7,9,11,13-HEXA(H3C-),4-((4,6-DI(H3C-),

4-(H3C-O-),5-(O=),6-(H3C-)-TETRAHYDROPYR-2-YL)-O-),6-

((3-(R1-O-),4-((H3C)2-N-),6-(H3C-)-TETRAHYDROPYR-2-YL)-

O-),7,10-(-O-),10,12-(-O-CH(-R2)-O-),12-(H5C2-)-

OXACYCLOTETRADECANE

WHERE R1 AND R2 ARE AS BEFORE DEFINED.

公开(公告)号：ZA7403085B

公开(公告)日：1975-05-28

申请号：ZA7403085

申请日：1974-05-14

Applicant: ABBOTT LAB

Inventor： JONES P ,  PAUVLIK J ,  TADANIER J ,  MARTIN J ,  MCALPINE J

IPC: C07H17/08 ,  C07C

CPC classification number: C07H17/08

公开(公告)号：ZA774580B

公开(公告)日：1978-06-28

申请号：ZA774580

申请日：1977-07-28

Applicant: ABBOTT LAB

Inventor： PERUN T ,  CARNEY R ,  MCALPINE J

IPC: C07H15/236 ,  A61K

Abstract: Described are novel derivatives of seldomycin factor 5 (XK-88-5) and particularly 3'-deoxyseldomycin factor 5, which exhibit improved activity against gram-positive and gram-negative bacteria resistant to aminoglycoside antibiotics, and a method of preparing them.

公开(公告)号：BE882507A

公开(公告)日：1980-09-29

申请号：BE200013

申请日：1980-03-28

Applicant: ABBOTT LAB

Inventor： CARNEY R ,  MCALPINE J

IPC: C07H15/224 ,  C07H ,  A61K

公开(公告)号：PH10395A

公开(公告)日：1977-03-04

申请号：PH15865

申请日：1974-05-27

Applicant: ABBOTT LAB

Inventor： JONES P ,  MARTIN J ,  TADANIER J ,  MCALPINE J ,  PAULIK J

IPC: C07H17/08 ,  C07G11/00

Abstract: 1463850 4 11 -Dioxy-4-oxo-erythromycin B derivatives ABBOTT LABORATORIES 19 June 1974 [21 June 1973] 27249/74 Heading C2C Novel compounds I and II in which R 5 is CH(R 7 )-SR 8 (where R 7 is hydrogen or C 1-6 alkyl and R 8 is C 1-6 alkyl) and R 6 is hydrogen or C 2-6 alkanoyl provided that when R 6 is hydrogen then R 5 is also hydrogen are prepared by reacting erythromycin B with a di-C 1-6 alkyl-sulphoxide and C 2-6 alkanoic acid anhydride to form a compound I (R 5 = CH(R 7 )-SR 8 and R 6 = C 2-6 alkanoyl) which is hydrolysed with an alkali metal bicarbonate to form a compound I (R 5 =CH(R 7 )-SR 8 and R 6 = hydrogen) which in the presence of HgO/ HgCl 2 forms a compound II which is hydrolysed by dil. HCl to compound I (R 5 = R 6 = hydrogen). Compound I (R 5 =R 6 =hydrogen) is also prepared by treating compound II with chloramine T.

公开(公告)号：BE885403A

公开(公告)日：1981-03-25

申请号：BE202236

申请日：1980-09-25

Applicant: ABBOTT LAB

Inventor： CARNEY R ,  MCALPINE J

IPC: A61K31/35 ,  A61P31/04 ,  C07H15/224 ,  C07D ,  A61K

公开(公告)号：ZA7704580B

公开(公告)日：1978-06-28

申请号：ZA7704580

申请日：1977-07-28

Applicant: ABBOTT LAB

Inventor： PERUN T ,  CARNEY R ,  MCALPINE J

IPC: C07H15/236 ,  A61K

CPC classification number: C07H15/234

公开(公告)号：ZA743085B

公开(公告)日：1975-05-28

申请号：ZA743085

申请日：1974-05-14

Applicant: ABBOTT LAB

Inventor： JONES P ,  PAUVLIK J ,  TADANIER J ,  MARTIN J ,  MCALPINE J

IPC: C07H17/08 ,  C07C

Abstract: 1463850 4 11 -Dioxy-4-oxo-erythromycin B derivatives ABBOTT LABORATORIES 19 June 1974 [21 June 1973] 27249/74 Heading C2C Novel compounds I and II in which R 5 is CH(R 7 )-SR 8 (where R 7 is hydrogen or C 1-6 alkyl and R 8 is C 1-6 alkyl) and R 6 is hydrogen or C 2-6 alkanoyl provided that when R 6 is hydrogen then R 5 is also hydrogen are prepared by reacting erythromycin B with a di-C 1-6 alkyl-sulphoxide and C 2-6 alkanoic acid anhydride to form a compound I (R 5 = CH(R 7 )-SR 8 and R 6 = C 2-6 alkanoyl) which is hydrolysed with an alkali metal bicarbonate to form a compound I (R 5 =CH(R 7 )-SR 8 and R 6 = hydrogen) which in the presence of HgO/ HgCl 2 forms a compound II which is hydrolysed by dil. HCl to compound I (R 5 = R 6 = hydrogen). Compound I (R 5 =R 6 =hydrogen) is also prepared by treating compound II with chloramine T.